Holen Sie sich die Stockscreener-App
11.49
0.09%
-0.010
Handel nachbörslich:
11.62
0.13
+1.13%
Schlusskurs vom Vortag:
$11.50
Offen:
$11.48
24-Stunden-Volumen:
1.81M
Relative Volume:
0.92
Marktkapitalisierung:
$779.31M
Einnahmen:
$65,400
Nettoeinkommen (Verlust:
$-46.34M
KGV:
-12.49
EPS:
-0.92
Netto-Cashflow:
$-38.74M
1W Leistung:
+5.80%
1M Leistung:
-23.25%
6M Leistung:
-7.49%
1J Leistung:
+143.95%
1-Tages-Spanne:
$11.38
$11.82
1-Wochen-Bereich:
$10.70
$11.92
52-Wochen-Spanne:
$3.61
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Firmenname
CorMedix Inc
Sektor
Branche
Telefon
908-517-9500
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Vergleichen Sie CRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
11.49 | 855.94M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-01-13 | Eingeleitet | D. Boral Capital | Buy |
| 2024-08-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-02-17 | Eingeleitet | Needham | Buy |
| 2020-09-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-09-21 | Eingeleitet | Truist | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2018-12-06 | Eingeleitet | ROTH Capital | Buy |
| 2017-09-25 | Bestätigt | H.C. Wainwright | Buy |
| 2017-08-10 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-05-05 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-11-11 | Bestätigt | FBR & Co. | Outperform |
| 2016-03-17 | Bestätigt | FBR Capital | Outperform |
| 2016-03-03 | Eingeleitet | FBR Capital | Outperform |
| 2015-11-16 | Bestätigt | ROTH Capital | Neutral |
| 2015-10-29 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Bestätigt | ROTH Capital | Buy |
| 2011-10-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
What drives CorMedix Inc. stock priceExceptional earning trajectories - Autocar Professional
What makes CorMedix Inc. stock attractive to long term investorsHigh-profit trading signals - jammulinksnews.com
What analysts say about CorMedix Inc. stockFree Predictions - PrintWeekIndia
Federal judge withdraws opinion after lawyer points out fake quotes, misstated case outcomes - ABA Journal
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention - MSN
CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock? - Yahoo Finance
NJ Fed. Judge Pulls Opinion Flagged With Nonexistent Quotes - Law360
Judge Scraps Opinion After Lawyer Flags Made-Up Quotes (Correct) - Bloomberg Law News
CorMedix Inc. Stock Analysis and ForecastFree Stock Market Beginners Guide - Autocar Professional
Is CorMedix Inc. a good long term investmentUnmatched market performance - Autocar Professional
CorMedix Inc. (CRMD) Plunges 1.90% to 2025 Low - AInvest
CorMedix Inc. (CRMD) Stock Analysis: Biotech's Hidden Gem With 71.64% Potential Upside - DirectorsTalk Interviews
Why CorMedix Inc. stock attracts strong analyst attentionFree Access to Community - Newser
What makes CorMedix Inc. stock price move sharplyFree Consultation - Newser
How CorMedix Inc. stock performs during market volatilityHigh Potential Safe Trades - Newser
CorMedix soars on increased Q2 sales guidance - MSN
Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive? - Yahoo Finance
CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study - TipRanks
(CRMD) Investment Analysis and Advice - news.stocktradersdaily.com
Important Notice to Long-Term Shareholders of CorMedix Inc. - GlobeNewswire
RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $18 - 富途牛牛
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph
CorMedix Completes $82.2 Million Stock Offering - The Globe and Mail
CorMedix stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com
CorMedix stock rating reiterated as Buy by H.C. Wainwright - Investing.com India
This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday - Benzinga
CorMedix slides after pricing $85M stock offering - MSN
CorMedix prices $85 million public offering of common stock By Investing.com - Investing.com South Africa
Finanzdaten der CorMedix Inc-Aktie (CRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):